Get notified when RPID files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Immediate Dilution of $1.30 Per Share (new) — New investors face significant immediate dilution of $1.30 per share, representing about 66% of the offering price.
- No Public Trading Market For the Pre-funded Warrants, Series A Common Stock Warrants or Series B Common Stock Warrants (new) — The warrants offered will not be listed on any exchange and no market is expected to develop, severely limiting liquidity for warrant holders.
- Series B Common Stock Warrants Will Have the Right to Require the Company to Repurchase Such Warrants For Consideration In an Amount Equal to the Black Scholes Value (new) — Series B warrant holders can force the company to repurchase warrants at Black Scholes value upon a fundamental transaction, creating a potential significant cash obligation.
- Dual-class / Super-voting Structure (new) — Prospectus discloses a dual-class or super-voting capital structure that concentrates voting power; public holders may have limited control over director elections and other matters requiring a stockholder vote.
Rapid Micro Biosystems prices $9.85M offering of 3.58M shares plus warrants at $1.955
Filed May 19, 2026 · ~1 min read
Key Changes
-
high
Company offering 3,581,000 Class A shares at $1.955, plus pre-funded warrants for 1,463,000 shares at $1.945, each with Series A and B warrants.
The Offering verify on EDGAR → -
high
Net proceeds to company estimated at $8.9M after discounts and expenses; potential additional $21.7M if all warrants exercised.
Use of Proceeds verify on EDGAR → -
high
New investors face immediate dilution of $1.30 per share; pro forma net tangible book value rises to $0.66 per share.
Dilution verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (GIS 10-Q) is open in full — no account needed.
Partner
Trade RPID commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 2, 2026 · How we verify